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Oj`eefives. This study tested the hypothesis that nonviable
myocardium can be identified by quantitative measurements
of regional myocardial blood How obtained using positron emis-
sion tomography in conjunction with a mathematical model of
nitrogen-13 (N-13) ammonia tracer kinetics .
Background. Under steady state basal conditions there is a
minimal level of blood flow required to sustain myoo-irdial whIM-
ity . Therefore, the hypothesis predicts that regions with flow
below a certain threshold are likely to be composed primarily of
sear.
Methods. Studies were conducted in 26 patients with chronic
myocardial infarction . Positron emission tomographic measure-
ments of basal regional myocardial blood flow (N-13 ammonia)
and fluorine-18 (F-18) fluorodeoxyglucose uptake were made and
correlated with information about coronary anatomy and regional
wall motion to assess myocardial viability .
Results. In patients with chronic myocardial infarction, normal
zone blood flow (0 .81 ± 0.32 ml/min per g [mean ± SD]) was
greater (p < 0 .02) than that of border zones (0 .59 ± 0.29 mllmin
Differentiation of viable from infarcted myocardium repre-
sents one of the more important cardiac applications of
positron emission tomography . Positron emission tomo-
graphic viability protocols typically use fluorine-18 (F-18)
fluorodeoxyglucose as a marker of myocardial glucose me-
tabolism and nitrogen-13 (N-13) ammonia as an indicator of
myocardial blood flow (1,2) . Other tracers, such as oxygen-15
water (3) and rubidium-82 (4) have also been used to assess the
correspondence between myocardial blood flow on the one
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per g), which in torn exceeded (p < 0
.001) that of infarct zone flow
(0 .27 ± 0,17 m1hain per g)
. Good correlation was noted between
relative F-18 fluorodeoxyglucose uptake and relative regional
myocardial blood flow in all zones (r = 0.63, p < 0.001) .
Mismatch between blood flow and F-18 fluorodeoxyglacose up-
take, with a single exception, was not observed in any segment
%with blood flow <0.25 mUinin per g. All dyskinefic'segmeats (a =
5) also had blood flow <0 .25 mi/min per g . In contrast, 43 of 45
myocardial segments (23 patients) with normal contraction or o
mild hypokinesia had slow ?0 .39 ml/min per g (average flow
0.78 :k 0.35 ml/min per g) .
Conclusions . In patients with chronic myocardial infarction,
myocardial viability is unlikely when basal regional myocardial
blood flow is <0 .25
ml/min
per g. Average basal flow in segm eaAs
with normal or nearly normal wall motion is 0 .78 :l: 0.35
ml/min
r g. Thus, positron emission tomographic measurement of
regional myocardial blood flow is helpful in identifying nonviable
myocardium in these patients .
(j Am Coil Cardiol 1994,23 :851-9)
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hand and myocardial metabolism (usually glucose) on the
other. In patients with healed myocardial infarction, infarct
zones with F-18 fluorodeoxyglucose uptake in excess of blood
flow frequently exhibit improved wall motion after coronary
artery revascularization and thus are thought to contain viable
myocardium (1,2). Accordingly, semiquantitative analysis of
positron emission tomographic perfusion and glucose metabo-
lism scans has become an accepted method for identification of
residual viable myocardium in regions of previous myocardial
infarction.
It is apparent, however, that a minimal level of myocar-
dial blood flow is required to maintain cell membrane integ-
rity and hence viability . The precise level may vary with
factors such as species and metabolic and physiologic con-
ditions . Because myocardial blood flow -1 ml/min per g is
required to maintain cell membrane integrity plus contrac-
tion under basal aerobic conditions in normal human myo-
cardium (5,6), the quantity of flow required to maintain
membrane integrity alone under otherwise identical condi-
tions must be considerably less, because the vast majority
(>75%) of oxygen consumption by the myocardium is de-
0735-1097/94/$7.00
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voted to contraction (7,8). Accordingly, this study tested the
hypothesis that chronically infarcted, nonviable myocar-
dium could be identified using positron emission tomography
and a mathematical model of N-13-ammonia tracer kinetics
to obtain quantitative measurements of regional myocardial
blood flow. The hypothesis predicts that chronic infarct
zones with very low flow compared with normally perfused
regions of the heart under basal physiologic conditions
should be composed largely of scar . Perfusion stu~ies were
obtained at rest in patients with documented chronic myo-
cardial infarction and were correlated not only with results
of metabolic (F-18 fluorodeoxyglucose) imaging but also of
regional wall motion analysis .
Meth(MIS
Patlesits. The study group was assembled prospectively
during a 9-month period from a larger group of ambulatory
outpatients initially referred for a clinically indicated thal-
lium stress test . Patients subsequently had a positron emis-
sion tornogritphic: myocardial perfusion study at rest with
N-13- • mmonia and a myocardial metabolism study with F-18
fluorodeoxyglucose if the following conditions were met .
The referring physician requested the positron emission
tomographic study, and the patient gave verbal informed
consent for the procedure . In addition, patients had to have
had historical and electrocardiographic (ECG) evidence of
previous myocardial infarction . Diabetic patients were ex-
cluded from the study group . Patients who had myocardial
infarction <2 months before the positron emission tomo-
graphic study or had cardiac catheterization >14 months
before the positron emission tomographic examination were
also excluded from the data base. The Human Studies
Committee of the Massachusetts General Hospital reviewed
and approved the cardiac imaging protocols for N-13 ammo-
nia and F-18 fluorodeoxyglucose .
All patients had undergone cardiac catheterization and
were clinically stable without recent (2 weeks) unstable
chest pain . The interval between positron emission tomo-
graphic scan and previous myocardial infarction ranged from
2 to 192 months (mean ± SD 44 ± 65) . Cardiac catheteriza-
tion was performed within 3 months of the positron emission
tomographic study in 7296 of patients (average for all pa-
tients 5 ± 4 months) . Cardiac and other medications were
continued as prescribed by the patient's physician .
IMM acquisition protocols . Positron emission tomo-
phic measurements were performed with a GE Medical
Systems/Scanditronix PC4096 tomograph that has been
described previously (9). Briefly, the scanner acquires 15
contiguous sections simultaneously with center to center
separation of 6.5 mm. Once positioned in the scanner, a
10-min transmission scan was performed . After this the
patient was given an intravenous injection of -25 mCi of
N-13 ammonia for 30 s . Dynamic tomographic imaging of the
heart was begun just before tracer injection. Data were
,.ollected for the Ist 4 min at 6 s/frame and then at 2
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min/frame for 10 min. Heart rate and arterial blood pressure
were monitored noninvasively with a Dynamap monitor
(model 845, Critikon) during the perfusion study in 12
consecutive patients. The radiation dose associated with the
N-13 ammonia study was 5 mR/mCi for whole body and 51
mR/mCi to the bladder (target organ) .
After completion of the rest myocardial perfusion study,
the patient was allowed to get up . Next, an oral glucose load
n=~ givca (Glucola, 100 g )i, followed -45 min later by an
intravenous injection of 7 .5 mCi of F-18 fluorodeoxyglucose .
One hour after the injection, the patient was repositioned in
the scanner, and a single 15-min image was obtained . After
completion of the F-18 fluorodeoxyglucose emission scan, a
second 10-min transmission scan was acquired and was used
for reconstruction of the F-18 fluorodeoxyglucose study .
Residual radioactivity in the patient was 30- to 40-fold less
than that of the germanium-68 pin source and thus did not
interfere with the second transmission scan . The radiation
dose associated with the F-18 fluorodeoxyglucose study was
39 mR/mCi for whole body and 440 mR/mCi to the bladder
(target organ) .
Image analysis . Attenuation-corrected N-13 ammonia
and F-18 fluorodeoxyglucose images were reconstructed
with a conventional filtered backprojection algorithm as
128 x 128 pixel images in the transverse plane normal to the
long axis of the body . Filtering of the projection data was
performed with a Manning filter to yield ow nut resolution of
7.8 mm (full-width, hall maximum) .
The N-13 ammonia scans (n = 5) corresponding to the last
10 min of data acquisition were summed to assist in identi-
fication of regions of interest for quantitative determination
of regional myocardial blood flow . The summed transverse
image was divided into septal, anterior and lateral segments .
In more caudal sections, the "lateral" segment samples the
inferoposterior region of the left ventricle . Regions of inter-
est were placed over each segment in four to five represen-
tative imnsverse sections, and time-activity were curves
generated from the initial 2 to 3 min of data . An arterial input
function was generated from a region of interest placed over
the left ventricular cavity of each section . Subsequently,
each set of curves was averaged to obtain a single arterial
input and representative myocardial time-activity function
for each segment .
The curves so obtained were then used as input to a
two-compartment, three-variable tracer kinetic model for
determination of regional myocardial blood flow. The model
used was similar to that described by others (5,6) . The first
compartment models the interface between blood and myo-
cardium, whereas the second models the pool of ammonia
converted to glutamine within the myocardium . Passage of
tracer into the myocardium from blood is primarily related
to passive diffusion and is given by KI (myocardial blood
flow x extraction fraction). In our model the rate of back-
diffusion of ammonia into the blood (k2 [min - ']) was fixed at
1.087 x KL The rate constant k3 (min-') describes conver-
sion of ammonia to gliltamine . A term to correct for tracer
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spillover and partial volume effect (Fb) was also incorpo-
rated in the model. The equations were solved by nonlinear
least-squares techniques using software (BLED) developed at
the National Institutes of Health . The arterial input function
was not corrected for recirculation of labeled ammonia
metabolites (6,10) .
Conversion of KI to regional myocardial blood flow
(ml/min per g) was performed on the basis of validation
experiments conducted in swine in which How was measured
simultaneously by colored mierosphcres and P013 ammonia
(Appendix). A nonlinear least-square technique was used to
fit the data obtained (KI and microsphere flow [QJ) to the
following model (5,6) to obtain estimates of PS (permeability
surface area product) and j (empiric constant) :
KI = Q x G -i
x e"'"SQ1
111
Once PS and j were known, a lookup table was constructed
that permitted conversion of KI to regional myocardial
blood flow .
Regions of interest equivalent to those and for the N13
ammonia scans were placed over appropriately matched
sections of the F-18 fluorodeoxyglucose scan to obtain an
objective measurement of regional F-18 fluorodeoxyglucose
uptake (nCi/m 1). Validation of methods for quantitation of
F-18 Fluorodeoxyglucose in terms of nCi/ml from our labo-
ratory have been described elsewhere (11) . The data were
averaged over the four to five sections that corresponded
best to those used for blood flow measurements . The value
of activity in the left ventricular blood pool that represented
background level in blood was subtracted from myocardial
activity in each section .
The following approach was used to compare regional
myocardial blood flow and F-18 fluorodeoxyglucose uptake .
The myocardial region with best flow was designated the
normal zone and was assigned a value of I in both N-13
ammonia and F-18 fluorodeoxyglucose scans (2) . Flow and
F-18 fluorodeoxyglucose uptake in other myocardial seg-
ments were normalized to the appropriate value in the
segment with best flow . Relative flow was then subtracted
from relative F 18 fluorodeoxyglucose uptake to determine
whether a "mismatch" between the two existed (2). A
mismatch was defined objectively as a difference >0 .34 and
was taken as one indicator of myocardial viability . The
cutoff value was obtained by doubling the standard deviation
of the average normal zone F-18 fluorodeoxyglucose- blood
flow difference observed in this study and adding it to the
average difference .
Myocardial regions were designated as normal, border or
infarct zones on the basis of objective measurements of
regional myocardia l, blood flow. Scan segments with flow
-75% of maximum were defined as normal . Border zones
had flow ?50% but <75% of maximum, whereas infarct
zones had flow <50% of maximum . All infarct zones so
defined corresponded to loci of previous myocardial infarc-
tion, as determined by historical and ECG criteria .
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Regional wall motion was used as another indicator of
myocardial viability . Segments having normal wall motion or
only mild hypokinesia were viable. in contrast, in the
long-term, healed phase of myocardial infarctior., regions
with dyskinesia represented scar . Severe hypokinesia or
akinesia in the setting of stable chronic ischemic hear
disease may occur in segments containing either viable
(presumably hibernating) myocardium (12) or scar, or both .
Comparison of regional wall motion and regional myocar-
dial blood flow was made on the basis of visual analysis of
contrast biplane left ventriculography in 21 of 26 patients .
All ventriculograms were interpreted without knowledge of
positron emission tomographic myocardial blood flow mea-
surements by the clinician who performed the cardiac cathe-
rization . In the remaining patients either a multiprojection
radionuclide ventrRukgraim (three patients) or echocardio-
gram (two patients) obtained close to the time of cardiac
catheterization was used for wall motion assessment .
All flow computations, including region of interest place-
ment, were made without knowledge of regional wall motion
data . Septal blood flow was paired with septal wall motion
and anterior segment blood flow with anterior and apical wall
motion. Because the "lateral" segment represents infero-
posterior myocardium in more caudal tomographic sections,
blood flow was paired with inferior or posterior wall motion
in such cases. When more cranial sections were sampled, as
with anterolateral myocardial infarction . blood flow was
paired with anterolateral wall motion .
Validation experiments. For a detailed explanation of the
validation experiments in swine . see Appendix (13-17) .
Stalk.fles . All data are expressed as mean value t SD .
The significance of difference` 9 etween group mean values
of myocardial blood flow were assessed first by unpaired f
tests . Values of p < 0 .05 were considered statistically
significant .
Ressits
Validation data. For results of validation experiments in
swine, see Appendix and Figure 1 .
Patient data . The study group consisted of 26 patients (25
men, I woman), with a mean age of 55 years (range 34 to 74) .
Healed myocardial infarction was anterior in 18 patients and
inferior in 8 . In addition I I of 26 patients had had revascu-
larization of the infarct zone (anterior in 7 and inferior in 4) .
The interval between revascularization and positron emis-
sion tomographic study was 11 ± 9 months .
Myocardial blood flow in patient . Normal zones (n = 40) .
Basal regional myocardial blood flow in normal segments
was 0.81 ± 0.32 ml/min per g
. There was no difference
among flow in anterior (0 .80 ± 0.29 ml/min per g, n = 9),
septal (0 .77 ± 0.29 ml/min per g, n = 13) and lateral (0
.86 ±
0.37 mi/min per g, n = 18) segments
. Normal zones that were
supplied by a coronary artery with >50% stenosis had flows
(0.70 ± 0
.19 ml/min per g, n = 15) that were marginally lower
(p = 0
.1) than those of segments supplied by a coronary
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artery that had <50% stenosis or that had been revascular-
ized (0.89 ± 0.37 ml/min per g, n = 23) . Segments supplied
by coronary vessels that were entirely free of stenosis (n =
7) had somewhat higher flows (0 .93 ± 0.50 ml/min per g) than
those of other subgroups, (p = NS) .
In a subset of normal segments (I I segments in 9 patients)
selected because they had been revascularized or were
perfused by a coronary artery with <50% stenosis, there was
a loose correlation between rate-pressure product (heart rate
times systolic arterial pressure) and regional myocardial
blood flow (r = 0 .56, p = 0 .07, r' = 0.31). Expression of flow
on a per beat basis did not reduce the scatter in the data (r
0.35, p = NS) .
Border and infarct zone
flow
and F-18 Puorodeowygh,
coss Myocardial segments with severe perfusion defects
were classified as infarct zones (n = 22) and had absolute
values of flows of 0 .27 ± 0.17 mUmin per g (p < 0 .001 vs .
both border and normal zones) . Segments with less severe
perfusion defects (i .e ., flow :' 50%r and <75% of maximum)
were considered border zones (n = 16) and had absolute
1 .80
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levels of flow (0 .59 ± 0.29 ml/min per g) intermediate by
definition between normal (p < 0.02) and infarct regions .
Further, as anticipated, revascularized infarct and border
segments (n = 16) had myocardial blood flow that was
greater than that of segments (n = 22) that were not (0 .52 ±
0.21 vs . 0.32 ± 0.29 ml/min per g, respectively, p < 0.02) .
Revascularized segments in general also had better wall
motion. Thus, 8 of 12 segments with normal or only mildly
abnormal wall motion had been revascularized, whereas 18
of 26 segments with more severe contraction abnormalities
had not (chi square = 4 .34, p < 0.05) .
The relation between normalized regional myocardial
blood flow and normalized F-18 fluorodeoxyglucose uptake
for all myocardial segments is shown in Figure 2 . Although
there is scatter in the data, a significant (r = 0 .63, p < 0.001)
correlation between the two variables is apparent . It should
also be noted that the majority (17 [78%] of 22) of infarct
segments lie very close to the regression line with slope of
1 .02 .
A plot of relative F-18 fluorodeoxyglucose minus relative
13
0.80 1 .00
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Figure 1 . Correlation between microsphere
(pSPHR) and positron emission tomo-
graphic (K I) measurements of regional myo-
cardial blood flow . A very close relation (KI
= 0.12 + 0.58 x microspheres, r
2 = 0.9,4)
ever a wide range of flows is apparent .
Figure 2. Relation between normalized
regional myocardial blood flow (RMBFrI)
(ml/min per g) and normalized F-18 fluo-
rodeoxyglucose (FDGrl) uptake is shown
here for all myocardial zones (n = 78) .
Data points with identical or nearly iden-
tical values appear only once, and thus
the total number of points is <78. The
regression line (solid line) demonstrates in
general that relative F-18 fluorodeoxyglu-
cose uptake is proportional to relative
blood flow (r = 0.63, p < 0.01) . Dashed
line represents the upper limit of normal
(mean + 2 SD) for F-18 fluorodeoxyglu-
cose-blood flow mismatch . Points above
the line have mismatch (i .e ., normalized
F-18 fluorodeoxyglucose >0.34 + nor-
malized regional myocardial blood flow) .
Mismatch did not occur at relative flow
<0.35 x normal . Open squares = normal
zone; plus signs = infarct zone ; solid
squares = border zone.
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Figure 3
. Relatiog between absolute values of regional myocardial
blood flow (RMBF) and normalized F-18 fluorodeoxyglucose/blood
flow difference (FI)GA-11MBF) for all myocardial zones
. The line at
0.34 along the ordinate corresponds to the upper limit of normal for
the difference between relative F-18 fluorodeoxyghcose up-
take and rr'itive blood flow
. Points above the line represent mis-
matched zones
. Mismatched zones are associated with myocardial
blood flow >0
.25 ml/min per g, with only one exception . Symbols as
in Figure 2 .
regional myocardial blood flow versus absolute regional
myocardial blood flow for all myocardial zones is shown in
Figure 3 and demonstrates with only a single exception that
"mismatch" does not occur when absolute flow is
<0.25 ml/min per g . The lone exception had flow of
0.24 mllmin per g. It should also be noted that mismatch was
not observed at relative flow <0 .35 times normal (Fig . 2) .
If a lower cutoff had been used to define mismatch (i .e .,
mean ± I SD instead of mean t 2 SD), then only one
additional segment (flow 0 .15 ml/min per g) would have
been observed . However, if the cutoff had been higher (i .e .,
mean ± 3 SD), then the lowest flow , !-,sociated with mis-
match would have been 0 .39 mllmin per g. Border and infarct
zones that had been revascularized were also more likely to
exhibit mismatch (six of nine) than those that had not (three
of nine) . The difference, however, was not statistically
significant, presumably because of sample size .
Regional myocardial blood flow versus regional wall
motion . A dyskinetic segment was noted in five patients and
involved the anterior wall and apex in each (Fig. 4) . Regional
myocardial blood flow in each aneurysm was <0
.25 ml/min
per g. Eleven of 12 segments (nine patients) with flow
<0.25 mllmin per g exhibited severe wall motion abnormal-
ities
. In addition to the five dyskinetic segments, there were
six segments (four patients) with severe hypokinesia or
akinesia. No segment with dyskinesia demonstrated F-18
fluorodeoxyglucose-blood flow mismatch .
In contrast, 96% of myocardial segments (43 of 45 seg-
ments in 23 patients) with normal contraction or only mild
hypokinesia had flow -0
.39 ml/min per g (average flow 0 .78
:: 0.35 mllmin per g)
. More than 759% of these segments had
flow ~:0.58 ml/min per g. Of all segments with flow
K39 mllmin per g, 74% (43 of 58 segments in 22 patients)
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Figure 4
. Cumulative percent of myocardial segments with dyski-
nesia (A) . akinesia or severe hypokinesia (B) and mild hypokinesia
or normal wall motion (C)
as a function of regional myocardial blood
flow (RAABF)
. All dysbrietic segments have flow <039 ml/min per g
(actually all are <0
.25 ml/min per g) versus -501X
with akinesia or
severe hypokine%ia and only 4% with mild hypokinesia or normal
wall motion .
exhibited normal or only mildly abnormal regional wall
motion
. Evidence of F-18 fluorodeoxyglucose- blood flow
mismatch occurred in five segments (five patients) with
normal or only mildly abnormal wall motion
.
Segments with severe hypokinesia or akinesia (28 seg-
ments, 17 patients) had flow j0
.39 ml/min per g in 15 (54%)
of 28 segments and demonstrated blood flow that was
intermediate (average flow 0 .42 ± 0.21 ml/min per g) be-
tween the extremes of flow in dyskinetic segments
(<0
.25 ml/min per g) and that of segments with normal or
only mildly abnormal wall motion (0 .78 ml/min per g) . In this
group, four segments (four patients) with F-18 fluorodeoxy-
glucose-blood flow mismatch were identified (three with
akinesia, and one with severe hypokinesia) .
Discussion
Study hypothesis
and major findings. The objective of this
study was to test the hypothesis that positron emission
tomographic measurement of absolute regional myocardial
blood flow with N-13 ammonia and a mathematical model of
tracer kinetics would be useful in identifying nonviable
myocardium in humans with healed myocardial infarction .
Myocardial viability was evaluated both by analysis of
regional wall motion and by objective assessment of the
relation between myocardial glucose metabolism and myo-
cardial blood flow (1,2)
. The data obtained indicate that the
hypothesis is correct because glucose metabolism-blood
flow mismatch (evidence of myocardial viability) was ob-
served only once with regional myocardial blood flow
<0.25 ml/min per g
. Further, no segment with dyskinetic
wall motion (an indicator of myocardial scar) had flow
>0
.25 mllmin per g . Both observations are consistent with
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established experimental data indicating that under basal
physiologic conditions >75% of myocardial oxygen con-
sumption in a normal beating heart is devoted to contraction
(7,8) . Accordingly, the level of myocardial blood flow re-
quired to fuel ion pumps and maintain cell intt grity in the
absence of contraction must be considerably less than "nor-
mal" levels of basal myocardial blood flow in khe beating
heart (-0.8 to 1 .0 ml/min per g) . Although a level of
0.25 ml/min per g (or <0.35 times normal zone flow) was
predictive under conditions of the present study, we recog-
nize that the precise blood flow level required for viability
may vary and could be different under other ex Oedmental
conditions . In addition, positron emission tomographic mean
surements of myocardial blood flow are not error free, and
potential technical limitations must be considered (see later,
Methodologic critique). Results of regional wall motion
analysis also demonstrated that 43 (96%) of 45 clearly viable
segments (i .e ., those with normal or only mildly abnormal
contraction) had regional blood flow =0 .39 mUruin per g and
that >75% had flow X0.58 mllmin per g. Thus, measurement
of absolute levels of myocardial blood flow under basal
conditions in patients with chronic myocardial infarction is
useful in identifying viable myocardium, as assessed by
regional wall motion criteria .
The present study used both regional wall motion and the
myocardial blood flow-F-18 fluorodeoxyglucose uptake re-
lation as complementary methods for providing an opera-
tional definition of myocardial viability . Although, the patho-
physiologic meaning of a °°mismatch" after glucose loading
in humans with chronic myocardial infarction is likely to be
different from that of fasted dogs (18-21) with acute myo-
cardial ischemia and infarction, empiric data in humans (1,2)
support the concept that mismatched zones frequently, but
not invariably, harbor viable myocardium . It is also very
likely that, on the basis of regional wall motion data obtained
in this study involving patients with stable, chronic ischemic
heart disease, myocardial regions with matched mild to
moderate reductions in flow and F-18 fluorodeoxyglucose
uptake (35 segments with flow >_0.39 and <0.75 ml/min
per g) contain a substantial amount of viable myocardium
because the majority of such regions (n = 25, 71%) exhibit
normal (n = 16) or only mildly abnormal (n = 9) contraction .
Related observations (i .e ., steady state, sustained reduction
in myocardial blood flow without myocardial infarction)
have been made both directly in animal experiments
(14,22,23) and indirectly in an earlier human study reported
from this laboratory (24) . Data from a more recent human
study (25) also support this view . Furthermore, the ability of
myocardium to consume oxygen is truly an indicator of its
viability (26) and positron emission tomographic measure-
ments of myocardial blood flow and oxygen consumption
(carbon-I1 acetate) are very closely correlated
in humans
with previous myocardial infarction (26,27) . However, the
utility of using blood flow measurements alone to evaluate
myocardial viability in patients with acute myocardial infarc-
JACC, Vol. 23, No . 4
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tion or unstable angina pectoris, or both, was not addressed
in the present study and requires investigation .
Coronary physiology ; basal normal zone flow. Positron
emission tomographic measurements of regional myocardial
blood flow in both normal volunteers (0.75 ± 0 .43 to 0 .88 ±
0.17 ml/min per g) and in the normal zone of patients with
ischemic heart disease (0 .80 ± 0.16 to 1 .03 ± 0.23 ml/min
per g) are remarkably similar despite differences in tracers
and mathematical models used (3,5,6,28) and agree well with
values obtained in the present study (0 .81 ± 0.32 ml/min
per g). The extent to which external determinants of oxygen
demand influence absolute levels of flow under rest condi-
tions in regions of normal myocardium remote from zones of
infarction has not been studied . The correlation between
normal zone myocardial blood flow and rate-pressure prod-
uct (r = 0.56, r 2 = 0.31, p = 0 .07) in the present study
exhibited substantial scatter and was not improved by ex-
pressing flow on a mUg per beat basis . Accordingly, myo-
cardial contractile state appears to be a more important
determinant of absolute levels of basal blood flow in these
zones in patients with previous myocardial infarction,
Comparison with other studies. Efforts to assess myocar-
dial viability (or lack thereof) in humans on the basis of
analysis of absolute regional myocardial blood flow alone, as
measured with current generation positron emission tome .
graphic scanners, have not been reported . Schelbert (29), in
a preliminary study, noted that infarct regions with N-13
ammonia uptake C20% of control generally exhibited re-
duced F-18 fluorodeoxyglucose uptake, whereas zones with
N-13 ammonia uptake >40% of control "invariably ," exhib-
ited F-18 fluorodeoxyglucose activity . Zones with N-13
ammonia uptake between 20% and 40% of control exhibited
an unpredictable pattern of F- 18 fluorodeoxyglucose uptake .
Absolute measurements, however, of regional myocardial
blood flow were not reported .
Similarly, studies reported by Tamaki et al . (30) and Fudo
et al. (31) did not use absolute levels of myocardial blood
flow in data analysis, and, more important, F-18 fluorode-
oxyglucose scans were obtained in subjects in the fasting,
not glucose-loaded, state. Further, F-18 fluorodeoxyglucose
scans were analyzed by visual inspection only . Semiquanti-
tative assessment of the relation between F-18 fluorodeoxy-
glucose uptake and regional myocardial blood flow was not
performed . Accordingly, it is difficult to compare results the
previous studies (30,31) with those of the present report .
Apparent F-18 fluorodeoxyglucose uptake in excess of flow
in three patients with dyskinetic myocardial segments in one
of the previous reports (31) most likely reflects important
methodologic differences, including fasting F- IS fluorodeox-
yglucose protocol, absence of information with regard to
blood flow in the region and subjective analysis of the F-18
fluorodeoxyglucose-blood flow relation.
Methodologlc critique. Positron emission tomographic
estimates of regional myocardial blood flow were validated
in a separate series of animal experiments by comparison
with measurements made by colored microspheres. The
JACC, Vol . 23, No. 4
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results of these experiments (Fig . 1) clearly demonstrate that
K I (flow times extraction fraction for N-13 ammonia) is very
closely correlated with regional myocardial blood flow over
a wide range of flows. Microsphere flows <0 .45 ml/min per
g, however, were not obtained in our animal experiments,
nevertheless, validation studies of positron emission tomo-
graphic-N-13 ammonia measurement of myocardial blood
flow have been reported in animal experiments very similar
to ours in which flows as low as 0 .09 ml/min per g were
observed (P) . Furthermore, positron emission tomographic
estimates of NK I (flow times extraction fraction) and regional
myocardial blood flow can be described by the modified
Renkin-Crone equi,uion (see equation 1) . The value of PS and
the empiric constant (j) determined from data obtained in our
animal experiments (1 .01 and 0 .49, respectively) agree
closely with validation data reported by others (1 .14 and 0 .62
[17]) in which very low flows were recorded . Indeed, the
Reakin-Crone model using constants derived from data ob-
tained in the present study provides a K I versus flow curve for
flows between 0.09 and 0.65 mUnfin per g that is indistinguish-
able from that obtained with previous values for these con-
stants (17). In addition, image resolution with the scanner used
in our report (7.8 mm full-width, half maximum) exceeded that
of the previous study (13 .4 mm [17]) . All of these consider-
ations strongly suggest in the present investigation that esti-
mates of transmural flows <0.45 ml/min per g are likely to be
reliable and very similar to those obtained at other institutions
using comparable methodology .
We recognize, however, that measurements of very low
flow by definition are subject to greater percent error than
are high flow measurements and that any dividing line
between categories involving a continuous variable (i .e .,
blood flow) will be associated with borderline cases that
could be classified either way . In the present study the
absolute error (1 SD) for flow measurements <0 .25 ml/min
per g was 0
.08 ± 0.03 ml/min per g and was comparable to
that of segments with flow between 0 .25 and 0 .45 mllmin per
g (0
.10 ± 0 .06 ml/min per g) and for segments with flows
>0.45 ml/min per g (0.11 ± 0.07 mUmin per g) . Thus, in
absolute terms, statistical errors were no greater for low flow
than for high flow values .
In terms of classification (viable, borderline, nonviable), a
1-SD change in flow would have moved 14 (20%) of 69
segments originally classified as either viable or nonviable by
flow criteria into the borderline category, but none would
have switched from viable to nonviable (or vice versa) . The
original nine borderline segments were excluded from this
analysis because they were borderline (0 .25 to 0 .39 ml/min
per g) by flow criteria to begin with
. A change of 2 SD in flow
would have caused 8 (12%) of 69 segments to be reclassified
from viable to nonviable or vice versa and an additional 17
(25%) of 69 to move to borderline status . It is therefore
apparent that shifting flow values by 1 or even 2 SD primarily
moves segments from the viable or the nonviable category
into borderline status . A change of status from one opposing
category to another (i .e., viable to nonviable or the reverse)
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would not have occurred with 1-SD shifts at any level of
measured flow and would have been observed with 2-SD
shifts in only 12% of segments . In the clinical realm, large
standard deviations for the data fit are always known, and
thus one is able to recognize less reliable flow estimates and
act accordingly .
Conclusions . The data obtained in the present study
indicate that positron emission tomographic measurement of
absolute levels of regional myocardial blood flow with N-13
ammonia can provide useful information with regard to
myocardial viability . After glucose loading in patients with
chronic stable ischemic heart disease, regions with basal
blood flow <0 .25 ml/mm per g under physiologic conditions
rarely demonstrate evidence of substantial F-18 fluorodeox-
yglucose uptake, usually have severe wall motion abnormal-
ities and are thus unlikely to contain an important compo-
nent of viable myocardium . In contrast, myocardial regions
with basal blood flow >0.39 ml/min per g are likely to
contain viable myocardium because at or above this level, 1)
96% of segments with normal or only mildly abnormal wail
motion were identified, and 2) 78% of F-18 fluorodeoxyglu-
cose/blood flow mismatches were observed . Further, of all
segments with flow >0 .39 ml/min per g, 74% had normal or
only mildly abnormal wall motion . Flows between 0 .25 and
0.39 mUmin per g under basal, physiologic conditions repre-
sent a transition region between high probability of nonvia-
bility and high probability of viability . Additional clinical
studies should be conducted to test the hypothesis that
quantitative measurements of regional myocardial blood
flow alone will be useful in predicting which regions with
long-term, severe wall motion abnormalities and reduced
myocardial blood flow will have improved contraction after
coronary revascularization procedures . Finally, appropriate
caution must be exercised in imerpreting absolute flow
values, particularly in the very low flow range . One must
consider carefully not only technical factors but also the
precise physiologic and metabolic circumstances under
which the measurements have been made .
We express our appreciation to the staff of the Cardiac Research laboratory of
Rhode Island Hospital and the Positron Emission Tomography laboratory at
Massachusetts General Hospital for superb technical support . Dawn Oliveira
and Audrey Valariani assisted in preparation of the manuscript .
Appendix
Validation of Positron Em!*ssion Tomographic
Measurement of Regional Myocardial Blood
Flow
Animal model. Closed chest domestic swine (n = 5) were prepared for the
study, as previously described (13-15) . Briefly, the pig was anesthetized with
halothane (0 .5% to 1 .5%) and nitrous oide (60:40 mixture in oxygen) and
placed on a volume-cycled ventilator
. Next, cutdowns were made over the
neck and both groins tc introduce catheters ((IF) into the descending aorta,
inferior vena cava and left atrium . In two pigs, a 3F balloon-tipped catheter
was also positioned in the mid to distal third of the left anterior descending
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coronary artery
. On completion of instrumentation, hemostasis was secured,
and wounds were closed, and the animal was permitted
to awaken from
anesthesia
. Once spontaneous respirations had resumed, the pig was sedated
with a continuous intravenous infusion of sodium thiamylal (20 to
30 g/h) to
ensure that it rested quietly and was free of pain
. The protocol was
approved
by the animal care and use committees of both the Rhode Island Hospital
and
the Massachusetts General Hospital and conforms to the "Position of the
A Heart Association on Research Animal
Use" adopted by the
Association in November 1984.
The pig was positioned in the tomograph,
right side down, and a
10-mir transmission scan was acquired, after which
baseline measurements of
hemoodynamic variables ( rate,
arterial and left atrial pressures) and
re ° nal myocardial blood flow were made . Blood flow
;measurements were
obtained by injecting colored microspheres (15-Am diameter (loo, EZ Track)
via the left atrial catheter
. Microspheres were given just before intravenous
is ection for 30 s of -10 mCi of N-13 ammonia
. The N-13 ammonia data were
acquired at 6 for the 1st 3 min and then 2 minlframe for the next
(min.
Aher completion of baseline
measurements, in three of the pigs an
intravenous infusion of adenosine was begun and increased progressively
until
mean arterial pressure declined by approximately
15 to 25 mm Hg, at which
time an intravenous infusion
. of phenylephrine was begun sufficient to increase
mean arterial pressure -25 mm Hg above baseline levels
. Both infusions were
maintained for 5 min, at which time a second injection
of colored micro-
spheres was given, followed shortly thereafter by an intravenous
injection of
10 mCi of N-13 ammonia with repeat dynamic image acquisition . In the
three
animals given adenosine, a third determination of myocardial blood flow
(microspheres and N-13 ammonia) and hemodynamie variables was made
-10 min after intravenous injection of propranolol (1 mg/kg body
weight) and
verapamil (5 to 10 mg) .
The remaining two pigs had partial coronary artery occlusion performed
by inflation of a double-lumen balloon-tipped catheter in the left anterior
descending coronary artery . The balloon was inflated to cause a substantial
pressure gradient (-40 to 60 mm Hg) between the aorta and the segment of
coronary artery distal to the balloon
. Measurements of hemodynamic vari-
ables and regional myocardial blood flow were made after 5
min of balloon
inflation . The balloon then was deflated, and the animal was permitted to
recover. Once the pig was stable, and after an appropriate time had elapsed
for decay of residual N-13 ammonia, a second occlusion was performed, and
repeat measurements of hemodynamic variables and regional myocardial
blood flow were obtained .
At the completion of data collection, the scanner's laser positioning guide
was used to assist in marking the animal's chest
. A series of marks were made
at -I-cm intervals to indicate the surface projection of several imaging planes
through the heart . Next, the pig was killed with Beuthanasia-D (20 ml
intravenously) . After death a long needle was used to perforate the heart at
several points along each plane of section to cut the heart for microsphere
determination of blood flow along lines that corresponded as closely as
possible to that of the scanner. Blue dye was injected after death distal to the
site of balloon i to assist in identifying the occlusion zone .
• N-13 anuwWa v Time-activity
carves three to five representative mid-left ventricular
scan sections
were obtained and ave ,
as previously described (see Image Analysis) .
The curves were generated from regions of interest that were placed over
anterior and posterior left ventricular walls . The estimates for K I (myocardial
blood flow
x
extraction fraction) obtained by nonlinear least-square fitting of
the positron emission to
hic data to the tracer kinetic model were
compared with the microsphere data by linear regression
. Statistical weights
inversely proportional to KI were used in the regression to control for
heteroscedacticity
.
Results (Fig. 1)
Regional myocardial blood flow by microsphere technique
ranged be-
tween 0.45 and 8
.11 ml/min per g, whereas values of KI ranged between 0 .34
and 4.21
. Avery close relation between KI and microsphere measurements of
regional myocardial blood flow was observed
. The overall F value was 345
(p <
0.01),
with r2 = 0.94 (p < 0
.001). The regression slope was 0 .58 ± 0
.03
(p < 0.
1 111)
. with an intercept of 0
.12 ± 0 .06 (p < 0.05). Further,
values
obtained for PS (permeability surface area product, 1
.01 ± 0.31), estimated by
nonlinear regression to the modified Crone model, and j (empiric
constant,
0.49 ± 0
.04) agreed closely with those reported by others
(1 . and 0.61,
respectively, [6] and more recently 1
.14 and 0.62, respectively (Ill) . Finally,
if data analysis is limited to blood flows <2
.5 ml/min per g (n = 21
data points),
the slope of the resulting regression line is 0
.67, and the intercept is nearly
zero (0.03), with rz = 0
.87 (p < 0.01).
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